![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bespak | LSE:BPK | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 667.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3102I Bespak PLC 31 August 2006 Bespak plc Directorate Change Bespak plc (LSE:BPK), a leader in speciality medical devices, is pleased to announce the appointment of George Kennedy, to the Board as a non-executive director. George will also become a member of the audit committee. George, 66, is currently Chairman of E2v plc, Deputy Chairman of Vernalis plc, senior Independent Director of Isotron plc, deputy Chairman of Spacelabs plc and Chairman of Eschmann Limited. He is a former Chairman of Smiths Industries Medical Group and past Chair of the ABHI. He is currently President of the ABHI. He was awarded the CBE in 1997 for services to Exports and to the Healthcare Industry. In accordance with Listing Rule 9.6.15, it is confirmed that there are no details to be disclosed pursuant to Listing Rule 9.6.13. Bespak also announces today the resignation of Jack Cashman and George Meredith as non-executive directors with effect from the close of the Company's Annual General Meeting to be held on 28th September. John Robinson, Bespak's Chairman commented, "I am delighted to welcome George Kennedy to the Board. His considerable experience of the healthcare industry will be of great benefit to Bespak. I would also like to thank Jack Cashman and George Meredith, who resign due to their other commitments, for their invaluable contributions to the Board over a number of years." For further information please contact: Bespak Mark Throdahl, Chief Executive Tel: +44 (0)1908 552600 Maitland Brian Hudspith or Liz Morley Tel: +44 (0)20 7379 5151 About Bespak plc Bespak, a leader in devices for inhaled drug delivery and anaesthesia, develops delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings. Bespak's product range includes metered dose and dry powder inhalers, actuators, inflation valves, breathing circuits, disposable face masks and laryngeal tubes. The group, which has facilities in King's Lynn and Milton Keynes in the UK and Indianapolis, Indiana and Kent, Ohio, in the US, in quoted on the Official List of the London Stock Exchange (LSE: BPK). For more information, please visit www.bespak.com. This information is provided by RNS The company news service from the London Stock Exchange END BOAWUUCCRUPQGWG
1 Year Bespak Chart |
1 Month Bespak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions